Search results for "Quotation"

showing 10 items of 18815 documents

The Clinical Efficacy of Radium-223 for Bone Metastasis in Patients with Castration-Resistant Prostate Cancer: An Italian Clinical Experience.

2017

<b><i>Background/Aim:</i></b> Prostate cancer frequently causes bone metastases and skeletal events that impair quality of life (QoL) and survival. The alpha emitter radium-223 is a new drug that improves treatment in men with castration-resistant prostate cancer (CRPC) and bone metastases. Our aim was to evaluate the effectiveness of radium-223. <b><i>Subjects and Methods:</i></b> In this retrospective study we enrolled 48 subjects. Pain reduction, alkaline phosphatase (ALP), time to first symptomatic skeletal event, and QoL were the variables we evaluated. <b><i>Results:</i></b> Radium-223 was well tolerated, with a m…

0301 basic medicineOncologyDrugRadium-223MaleCancer Researchmedicine.medical_specialtymedia_common.quotation_subjectAntineoplastic AgentsBone NeoplasmsDocetaxel03 medical and health sciencesProstate cancer0302 clinical medicineQuality of lifeInternal medicinemedicineHumansmedia_commonAgedRetrospective StudiesAged 80 and overRadioisotopesbusiness.industryBone metastasisRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseProstatic Neoplasms Castration-Resistant030104 developmental biologyOncologyDocetaxelItaly030220 oncology & carcinogenesisQuality of LifeAlkaline phosphatasePrednisoneTaxoidsRadium-223 Bone metastasis Prostate cancer Radiopharmaceuticals Metastatic castration-resistant prostate cancer Quality of Lifebusinessmedicine.drugRadiumOncology
researchProduct

Intermittent targeted therapies and stochastic evolution in patients affected by chronic myeloid leukemia

2016

Front line therapy for the treatment of patients affected by chronic myeloid leukemia (CML) is based on the administration of tyrosine kinase inhibitors, namely imatinib or, more recently, axitinib. Although imatinib is highly effective and represents an example of a successful molecular targeted therapy, the appearance of resistance is observed in a proportion of patients, especially those in advanced stages. In this work, we investigate the appearance of resistance in patients affected by CML, by modeling the evolutionary dynamics of cancerous cell populations in a simulated patient treated by an intermittent targeted therapy. We simulate, with the Monte Carlo method, the stochastic evolu…

0301 basic medicineOncologyDrugStatistics and Probabilitymedicine.medical_specialtymedicine.medical_treatmentmedia_common.quotation_subjectTargeted therapy03 medical and health sciencesClassical Monte Carlo simulations; computational biology; models for evolution (theory); mutational and evolutionary processes (theory); Statistical and Nonlinear Physics; Statistics and Probability; Statistics Probability and Uncertainty0302 clinical medicinecomputational biologyInternal medicinemedicineClassical Monte Carlo simulationmutational and evolutionary processes (theory)media_commonbusiness.industryMyeloid leukemiaStatistical and Nonlinear PhysicsImatinibSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)Axitinib030104 developmental biology030220 oncology & carcinogenesisCancer cellToxicityStatistics Probability and Uncertaintybusinessmodels for evolution (theory)Tyrosine kinasemedicine.drugStatistical and Nonlinear Physic
researchProduct

Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer

2016

Despite recent progress in understanding the cancer signaling pathways and in developing new therapeutic strategies, however, the resistance of colorectal cancer (CRC) cells to chemo- and radiotherapy represents the main hurdle to the successful treatment, leading to tumor recurrence and, consequently, a poor prognosis. Therefore, overcoming drug and radiation resistance, enhancing drug and radiation sensitivity of CRC cells, and improving the effi cacy of chemo- and radiotherapy have an important signifi cance in the treatment of CRC. The identifi cation of new molecular biomarkers which can predict therapy response and prognosis is one of the most signifi cant aims in pharmacogenomics and…

0301 basic medicineOncologyDrugmedicine.medical_specialtyColorectal cancermedicine.medical_treatmentmedia_common.quotation_subjectTherapy responseBiologyTargeted therapyTargeted therapy03 medical and health sciences0302 clinical medicineRadioresistanceInternal medicinemicroRNAmedicineChemotherapyNon-coding RNAneoplasmsChemoresistance; Chemotherapy; miRNAs; Non-coding RNA; Predictive biomarkers; Radioresistance; Radiotherapy; Targeted therapy; Therapy response; Medicine (all); Biochemistry Genetics and Molecular Biology (all)miRNAmedia_commonChemotherapyBiochemistry Genetics and Molecular Biology (all)RadiotherapyMedicine (all)Radioresistancemedicine.diseaseRadiation therapyPredictive biomarker030104 developmental biology030220 oncology & carcinogenesisPharmacogenomicsChemoresistance
researchProduct

Recent Insights into the Development of Preclinical Trastuzumab- Resistant HER2+ Breast Cancer Models.

2018

Background: Overexpression and amplification of the human epidermal growth factor receptor 2 (HER2) occur in 20% of total breast carcinomas. HER2-overexpression is implicated in disease initiation and progression and associated with poor prognosis. Trastuzumab, a humanized monoclonal antibody, is the standard HER2-targeted therapy for early and metastatic HER2-amplified breast cancer patients. Trastuzumab has significantly increased clinical benefit in HER2+ metastatic and adjuvant settings; however, it is not effective for many patients due to primary or acquired resistance to the drug. During the last decade, many studies have revealed a number of novel molecular traits of HER2+ breast c…

0301 basic medicineOncologyDrugmedicine.medical_specialtymedicine.drug_classReceptor ErbB-2medicine.medical_treatmentmedia_common.quotation_subjectBreast NeoplasmsDiseaseMonoclonal antibodyBiochemistryTargeted therapy03 medical and health sciences0302 clinical medicineBreast cancerAcquired resistanceAntineoplastic Agents ImmunologicalTrastuzumabInternal medicineCell Line TumorDrug DiscoverymedicineBiomarkers TumorAnimalsHumansskin and connective tissue diseasesneoplasmsmedia_commonPharmacologybusiness.industryOrganic ChemistryTrastuzumabmedicine.diseaseGene Expression Regulation Neoplastic030104 developmental biologyDrug Resistance Neoplasm030220 oncology & carcinogenesisMolecular MedicineFemalebusinessAdjuvantmedicine.drugCurrent medicinal chemistry
researchProduct

Prognostic Challenges of SCN1A Genetic Mutations: Report on Two Children with Mild Features

2016

Mutations in the gene encoding the α-1 subunit of the voltage-gated sodium channel (SCN1A) are associated with variable but usually severe clinical course, both for the epileptic seizures and the cognitive impairment. The purpose of the present study was to retrospectively review two patients affected by seizures and two different types of SCN1A gene mutations (microdeletion and point mutation). The children (a 4-year-old girl and a 3-year-old boy) were affected by generalized tonic–clonic seizures and myoclonic jerks plus unilateral seizures, respectively. Genetic analyses showed, in the girl, the presence of a 4 MB deletion involving SCN1A and four other genes, and a point mutation in the…

0301 basic medicinePediatricsmedicine.medical_specialtybusiness.industryPoint mutationmedia_common.quotation_subjectSodium channel geneMyoclonic JerkClinical course030105 genetics & hereditymedicine.disease03 medical and health sciences0302 clinical medicineDravet syndromePediatrics Perinatology and Child HealthGenotypemedicineNeurology (clinical)GirlbusinessGene030217 neurology & neurosurgerymedia_commonJournal of Pediatric Neurology
researchProduct

Actual and perceived weight status and its association with slimming and energy-balance related behaviours in 10- to 12-year-old European children: t…

2016

Both parents' and children's perception of children's weight status may be important predictors of slimming and energy-balance related behaviours, independent of children's actual weight status.; We examined the cross-sectional association of children's self-reported slimming and energy-balance related behaviours with children's (i) actual, (ii) self-perceived and (iii) parent-perceived weight status.; Data of 10- to 12-year-old European children and their parents were used. Multilevel logistic and linear regression analyses were performed, adjusting for age, gender, parental weight controlling behaviours, education, marital status and ethnicity.; Independent of their actual weight status, …

0301 basic medicinePediatricsmedicine.medical_specialtymedia_common.quotation_subjectEnergy (esotericism)Physical activityOverweight03 medical and health sciencesScreen time0302 clinical medicinePerceptionMedicine030212 general & internal medicineAssociation (psychology)media_common030109 nutrition & dieteticsNutrition and Dieteticsbusiness.industryHealth PolicyPublic Health Environmental and Occupational HealthPediatrics Perinatology and Child HealthMarital statusmedicine.symptombusinessDietingDemographyPediatric Obesity
researchProduct

Quantum field inspired model of decision making: Asymptotic stabilization of belief state via interaction with surrounding mental environment

2018

This paper is devoted to justification of quantum-like models of the process of decision making based on the theory of open quantum systems, i.e. decision making is considered as decoherence. This process is modeled as interaction of a decision maker, Alice, with a mental (information) environment ${\cal R}$ surrounding her. Such an interaction generates "dissipation of uncertainty" from Alice's belief-state $\rho(t)$ into ${\cal R}$ and asymptotic stabilization of $\rho(t)$ to a steady belief-state. The latter is treated as the decision state. Mathematically the problem under study is about finding constraints on ${\cal R}$ guaranteeing such stabilization. We found a partial solution of th…

0301 basic medicinePersuasionClass (set theory)Psychology (all)Quantum decoherenceDissipation of uncertaintyProcess (engineering)Computer sciencemedia_common.quotation_subjectBF050105 experimental psychology03 medical and health sciences0501 psychology and cognitive sciencesQuantum field theoryQAQuantumGeneral Psychologymedia_commonQuantum-like modelVoters’ behaviorApplied Mathematics05 social sciencesState (functional analysis)16. Peace & justiceMental environmentMental (information) environment030104 developmental biologyQuantitative Biology - Neurons and CognitionOpen quantum systemFOS: Biological sciencesConsumers’ persuasionNeurons and Cognition (q-bio.NC)Decision makingMathematical economics
researchProduct

Treatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds

2018

Two major obstacles for successful cancer treatment are the toxicity of cytostatics and the development of drug resistance in cancer cells during chemotherapy. Acquired or intrinsic drug resistance is responsible for almost 90% of treatment failure. For this reason, there is an urgent need for new anticancer drugs with improved efficacy against cancer cells, and with less toxicity on normal cells. There are impressive examples demonstrating the success of natural plant compounds to fight cancer, such as Vinca alkaloids, taxanes, and anthracyclines. Artesunic acid (ARTA), a drug for malaria treatment, also exerts cytotoxic activity towards cancer cells. Multidrug resistance often results fro…

0301 basic medicinePharmaceutical ScienceDrug resistancePharmacologychemotherapyAnalytical Chemistry0302 clinical medicineartemisinin egonol thymoquinone hybridsDrug DiscoveryBenzoquinonesCytotoxic T cellCytotoxicitymedia_commonLeukemiaChemistryNaturwissenschaftliche FakultätArtemisininsDrug Resistance MultipleGene Expression Regulation NeoplasticMolecular Docking SimulationChemistry (miscellaneous)030220 oncology & carcinogenesisddc:540multi-drug resistanceMolecular Medicinemedicine.drugDrugCell Survivalmedia_common.quotation_subjectAntineoplastic AgentsArticlelcsh:QD241-44103 medical and health scienceslcsh:Organic chemistryCell Line TumormedicineHumansDoxorubicinPhysical and Theoretical Chemistrychemotherapy; multi-drug resistance; artemisinin egonol thymoquinone hybridsCell ProliferationOrganic ChemistryCancerSuccinatesmedicine.diseaseMultiple drug resistance030104 developmental biologyDoxorubicinDrug Resistance NeoplasmCancer cellATP-Binding Cassette TransportersMolecules
researchProduct

α1-adrenoceptor activity of β-adrenoceptor ligands – An expected drug property with limited clinical relevance

2020

Many β-adrenoceptor agonists and antagonists including several clinically used drugs have been reported to also exhibit binding to α1-adrenoceptors. Such promiscuity within the adrenoceptor family appears to occur more often than off-target effects of drugs in general. It should not be considered surprising based on the amino acid homology among the nine adrenoceptor subtypes including the counter-ions for binding the endogenous catecholamines. When β-adrenoceptor ligands also bind to α1-adrenoceptors, they almost always act as antagonists, regardless of being agonists or antagonists at the β-adrenoceptor. The α1-adrenoceptor affinity of β-adrenoceptor ligands in most cases is at least one,…

0301 basic medicinePharmacologyDrugAdrenergic receptorChemistrymedia_common.quotation_subjectEndogenyPharmacologyα1 adrenoceptorIn vitroβ adrenoceptor03 medical and health sciences030104 developmental biology0302 clinical medicineClinical significanceReceptor030217 neurology & neurosurgerymedia_commonEuropean Journal of Pharmacology
researchProduct

Paracetamol – An old drug with new mechanisms of action

2020

Paracetamol (acetaminophen) is the most commonly used over-the-counter (OTC) drug in the world. Despite its popularity and use for many years, the safety of its application and its mechanism of action are still unclear. Currently, it is believed that paracetamol is a multidirectional drug and at least several metabolic pathways are involved in its analgesic and antipyretic action. The mechanism of paracetamol action consists in inhibition of cyclooxygenases (COX-1, COX-2, and COX-3) and involvement in the endocannabinoid system and serotonergic pathways. Additionally, paracetamol influences transient receptor potential (TRP) channels and voltage-gated Kv7 potassium channels and inhibits T-t…

0301 basic medicinePharmacologyDrugPhysiologybusiness.industrymedia_common.quotation_subjectdigestive oral and skin physiologyAnalgesicPharmacologySerotonergicEndocannabinoid systemAcetaminophen03 medical and health sciencesTransient receptor potential channel030104 developmental biology0302 clinical medicineMechanism of actionCOX-3030220 oncology & carcinogenesisPhysiology (medical)medicinemedicine.symptombusinessmedia_commonmedicine.drugClinical and Experimental Pharmacology and Physiology
researchProduct